Cholinergic Antagonists Overview
36 Questions
4 Views

Cholinergic Antagonists Overview

Created by
@FriendlyTrust

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism of action for atropine regarding M receptors?

  • It enhances the action of ACh at the receptor sites.
  • It binds irreversibly to M receptors.
  • It competitively blocks ACh and other cholinergic agonists. (correct)
  • It activates N receptors selectively.
  • Which of the following statements about atropine's selectivity is true?

  • Atropine primarily targets the M1 subgroup of muscarinic receptors.
  • Atropine is equally potent at M and N receptors.
  • Atropine is highly selective for M receptors with low potency at N receptors. (correct)
  • Atropine has a higher affinity for N receptors than M receptors.
  • What physiological effect does atropine have on the eye?

  • Causes constriction of the pupils.
  • Results in persistent mydriasis and cycloplegia. (correct)
  • Leads to increased secretion of tears.
  • Improves near vision by enhancing ciliary muscle activity.
  • How can the effects of atropine be overcome?

    <p>By increasing the concentration of ACh or using equivalent muscarinic agonists.</p> Signup and view all the answers

    Which muscarinic effects are specifically blocked by atropine?

    <p>Cholinergic activity of the pupillary sphincter and ciliary muscles.</p> Signup and view all the answers

    What is a primary use of atropine in conjunction with neostigmine?

    <p>To reverse parasympathomimetic effects after surgery</p> Signup and view all the answers

    Which of the following is a common adverse effect of atropine poisoning?

    <p>Blurred vision</p> Signup and view all the answers

    What distinguishes scopolamine from atropine in terms of physiological effects?

    <p>Scopolamine produces marked central effects and drowsiness</p> Signup and view all the answers

    Why is the use of atropine for inducing mydriasis and cycloplegia in older individuals considered risky?

    <p>It may worsen an attack of glaucoma</p> Signup and view all the answers

    How does atropine's elimination in the body occur?

    <p>Mainly unchanged in the urine</p> Signup and view all the answers

    What is the primary mechanism of action of muscarinic cholinoreceptor antagonists?

    <p>They competitively bind to M cholinergic receptors, inhibiting acetylcholine's action.</p> Signup and view all the answers

    Which agent is commonly classified as an antimuscarinic drug?

    <p>Atropine</p> Signup and view all the answers

    What effect do muscarinic cholinoreceptor antagonists primarily block?

    <p>Parasympathetic autonomic discharge</p> Signup and view all the answers

    What is a common therapeutic use of antimuscarinic agents?

    <p>Managing motion sickness</p> Signup and view all the answers

    Why are ganglionic blockers not widely used in clinical practice?

    <p>They possess diffuse actions with low selectivity.</p> Signup and view all the answers

    What is the primary effect of atropine at therapeutic doses?

    <p>Mild peripheral effects with minimal central effects</p> Signup and view all the answers

    Which of the following is NOT a type of cholinergic antagonist mentioned?

    <p>Antatropinic</p> Signup and view all the answers

    Which areas of the body are most sensitive to the effects of atropine?

    <p>Salivary, bronchial, and sweat glands</p> Signup and view all the answers

    Which neuromuscular blocking agent is least selective in causing ganglionic blockade?

    <p>Tubocurarine</p> Signup and view all the answers

    What is the primary therapeutic use of neuromuscular blocking agents during surgery?

    <p>Relax skeletal muscle</p> Signup and view all the answers

    Which neuromuscular blocker is primarily degraded by spontaneous plasma hydrolysis?

    <p>Atracurium</p> Signup and view all the answers

    What is a major side effect from the release of histamine triggered by neuromuscular blocking agents?

    <p>Hypotension</p> Signup and view all the answers

    What characteristic do all neuromuscular blocking agents share regarding their administration?

    <p>Intravenous injection</p> Signup and view all the answers

    Which of the following is preferred for controlling muscle spasms rather than neuromuscular blockers?

    <p>Botulinum toxins</p> Signup and view all the answers

    Which agent is known to cause the release of histamine that may provoke seizures due to its metabolite?

    <p>Atracurium</p> Signup and view all the answers

    Which neuromuscular blocker is known for having a vagolytic action that can lead to tachycardia?

    <p>Pancuronium</p> Signup and view all the answers

    What effect does ganglionic blockade primarily have on blood pressure?

    <p>It causes a gradual decrease in arteriolar and venous tone.</p> Signup and view all the answers

    Which condition may be exacerbated by ganglionic blockade in males?

    <p>Prostatic hyperplasia.</p> Signup and view all the answers

    Which neuromuscular blocker is known for causing complete muscle relaxation during surgery?

    <p>Curare.</p> Signup and view all the answers

    Which substance is primarily affected by nondepolarising neuromuscular blockers?

    <p>Skeletal muscle N receptors.</p> Signup and view all the answers

    What is a common clinical application of mecamylamine?

    <p>To reduce nicotine craving.</p> Signup and view all the answers

    What occurs in the gastrointestinal tract as a result of ganglionic blockade?

    <p>Reduced secretions and profoundly inhibited motility.</p> Signup and view all the answers

    Which of the following drugs acts peripherally by interfering with calcium release from muscle cells?

    <p>Botulinum toxin.</p> Signup and view all the answers

    Which outcome is expected after a ganglionic blockade regarding heart rate?

    <p>Moderate tachycardia may occur.</p> Signup and view all the answers

    What does the term 'curare' refer to?

    <p>Various South American arrow poisons used to paralyze prey.</p> Signup and view all the answers

    Which characteristic describes depolarizing neuromuscular blockers?

    <p>They are structural analogs of acetylcholine.</p> Signup and view all the answers

    Study Notes

    Cholinergic Antagonists:

    • Cholinergic antagonists are drugs that block the effects of acetylcholine (ACh) at cholinergic receptors.
    • They are divided into antimuscarinic (M receptor blockers) and antinicotinic (Nicotinic receptor blockers).
    • Most clinically useful are antimuscarinic agents and neuromuscular blocking agents.
    • Ganglionic blockers have limited clinical usefulness due to their broad actions and lack of selectivity.

    Antimuscarinic Agents:

    • Antimuscarinic agents, also called parasympatholytics, block the effects of parasympathetic autonomic discharge.
    • They competitively bind to M cholinergic receptors, inhibiting ACh’s stimulatory effects.
    • They also block some sympathetic neurons that are cholinergic, like those innervating salivary and sweat glands.
    • Antimuscarinic agents are beneficial in various clinical situations.
    • They do not block N cholinergic receptors, therefore they lack skeletal neuromuscular or autonomic ganglia effects.

    Atropine:

    • Atropine is a tertiary amine alkaloid ester of tropic acid.
    • It is found in plants like Atropa belladonna and Datura stramonium.
    • At therapeutic doses, atropine acts mainly peripherally, with minimal CNS effects.
    • Tissues most sensitive to atropine are salivary, bronchial, and sweat glands.
    • Atropine's duration of action is around 4 hours, but its effects in the eye can last for days.

    Atropine - MOA:

    • Atropine and its related compounds have a higher affinity for M receptors.
    • They bind competitively to the common site on cholinergic receptors, blocking ACh and other cholinergic agonists.
    • Atropine's blockade can be overcome by increasing the concentration of ACh or using a muscarinic agonist.
    • Atropine is highly selective for M receptors, with much lower potency at N receptors, but does not discriminate between M1, M2, and M3 receptors.

    Atropine – Physiological Actions:

    • Eye: Atropine blocks cholinergic activity of the pupillary sphincter muscles and ciliary muscles, causing mydriasis (dilated pupil), unresponsiveness to light, cycloplegia (paralysis of ciliary muscles), and inability to focus for near vision.
    • Antisecretory agent: Used to block secretions in the respiratory tract prior to surgery.
    • Anaesthesia: Used with neostigmine to reverse skeletal muscle relaxation after surgery.

    Atropine - PK:

    • Atropine is readily absorbed from the GIT and the conjuctival membrane, and well distributed throughout the body, including the CNS.
    • It is partially metabolized by the liver with a plasma half-life of 2-4 hours.
    • Its effects on parasympathetic function decline rapidly in all organs except the eye.
    • About 60% of the dose is eliminated unchanged in the urine.

    Atropine - A/E:

    • Poisoning manifests as dry mouth, blurred vision, tachycardia, hot & flushed skin, urinary retention, and constipation.
    • Body temperature is often elevated.
    • CNS effects include restlessness, confusion, hallucinations, delirium, depression, circulatory/respiratory collapse, and death.
    • Atropine's use for mydriasis and cycloplegia in older individuals is risky due to potential glaucoma exacerbation.

    Scopolamine:

    • Scopolamine is another belladonna alkaloid with peripheral effects similar to atropine, but has greater CNS action and a longer duration of action.

    Scopolamine – Physiological Actions:

    • Scopolamine has marked central effects, producing drowsiness and amnesia (loss of short-term memory) at therapeutic dosages.

    Ganglionic Blockers:

    • Ganglionic blockers act by blocking the transmission of nerve impulses through autonomic ganglia.
    • They have limited clinical usefulness due to their diffuse actions and lack of selectivity.
    • Examples include trimethaphan, mecamylamine, hexamethonium, and tetraethylammonium.

    Cardiovascular Effects of Ganglionic Blockade:

    • Decreased arteriolar and venous tone, leading to a gradual decrease in BP.
    • Moderate tachycardia may occur due to decreased parasympathetic dominance at the sinoatrial node.

    Other Organ System Effects of Ganglionic Blockade:

    • GIT: Reduced secretions and profound inhibition of motility, potentially causing constipation.
    • Genitourinary: Ganglionic blockade can precipitate urinary retention in men with prostatic hyperplasia.
    • Sexual functions: Impaired erection and ejaculation.
    • Thermoregulatory sweating is blocked.

    Clinical Application of Ganglionic Blockers:

    • Rarely used due to the availability of selective autonomic blocking agents.
    • Mecamylamine has been studied for use in reducing nicotine craving, treating moderate to severe hypertension, and as an alternative therapy for hypertensive crises.
    • Trimethaphan is occasionally used in the treatment of hypertensive crises.

    Neuromuscular Blocking Drugs:

    • These drugs block cholinergic transmission at the neuromuscular junction of skeletal muscle, resulting in muscle relaxation.
    • They are divided into nondepolarising (competitive) blockers and depolarizing blockers.
    • Clinically useful during surgery to achieve muscle relaxation.
    • Other muscle relaxants include centrally acting agents like diazepam and baclofen, and peripherally acting agents like dantrolene and botulinum toxin.

    Nondepolarising (Competitive) Blockers:

    • They act by competitively binding to the N receptors at the neuromuscular junction, blocking the action of ACh.
    • Examples include curare, tubocurarine, pancuronium, mivacurium, metocurine, doxacurium, vecuronium, and rocuronium.
    • They have variable potencies in producing ganglionic blockade, with tubocurarine being the least selective.
    • Some, like pancuronium, have vagolytic action due to muscarinic receptor blockade and lead to tachycardia.

    Therapeutic Uses of Nondepolarising Blockers:

    • Used as adjuvant drugs to relax skeletal muscle during surgery and orthopedic procedures.
    • Employed in procedures like intubation, bronchoscopy, and esophagoscopy.
    • Used in psychiatry to prevent trauma during electroconvulsive therapy (ECT).
    • Control of muscle spasms – botulinum toxins are preferred.

    PK of Nondepolarising Blockers:

    • All are injected IV due to poor oral absorption.
    • They penetrate membranes poorly and do not enter cells or cross the BBB.
    • Most are excreted unchanged in the urine.
    • Atracurium is degraded spontaneously in plasma and by ester hydrolysis.
    • Atracurium has been replaced by cisatracurium due to histamine release and laudanosine formation, which can cause seizures.
    • Vecuronium and rocuronium are deacetylated in the liver, with prolonged clearance in patients with hepatic disease.

    Drug Interactions:

    • Cholinesterase Inhibitors: These drugs increase ACh concentrations, potentially overcoming neuromuscular blockade. Examples include neostigmine and pyridostigmine.
    • Antibiotics: Some antibiotics can potentiate neuromuscular blockade. Examples include aminoglycosides (e.g., gentamicin) and macrolides (e.g., erythromycin).
    • Anesthetics: Volatile anesthetics can enhance neuromuscular blockade.
    • Other Drugs: Diuretics, lithium, and corticosteroids can also increase the effects of nondepolarising blockers.

    Depolarizing Blockers:

    • They cause depolarisation of the muscle membrane, initially leading to a brief period of muscle twitching followed by paralysis.
    • The main example is succinylcholine.
    • Short duration of action and rapid onset.
    • Used for rapid intubation, and in combination with non-depolarizing agents to prolong paralysis.

    Depolarising Blockers – MOA:

    • Succinylcholine binds to the N receptors at the neuromuscular junction, mimicking ACh and causing a prolonged depolarization.
    • This prolonged depolarization prevents further ACh binding, resulting in paralysis.

    PK of Depolarizing Blockers

    • Rapidly hydrolyzed by plasma cholinesterase.
    • Short duration of action.
    • Has a phase I (depolarizing) and phase II (desensitisation) effect.
    • Metabolic breakdown is affected by atypical cholinesterase activity.

    A/E of Depolarizing Blockers

    • Hyperkalemia.
    • Malignant hyperthermia.
    • Rhabdomyolysis.
    • Muscle pain.
    • Cardiovascular effects (bradycardia).

    Interactions of Depolarizing Blockers

    • Cholinesterase inhibitors can prolong the effects of succinylcholine.
    • Antibiotics may enhance the effects.
    • Anesthetics may influence the effect.
    • Other drugs may interact.

    Adverse Effects of Antimuscarinic Agents:

    • Dry mouth, blurred vision, photophobia, tachycardia, urinary retention, constipation, CNS effects (restlessness, confusion, hallucinations, delirium), and hyperthermia.
    • Contraindications include narrow-angle glaucoma, urinary retention, and megacolon.

    Adverse Effects of Neuromuscular Blocking Agents:

    • Respiratory depression, muscle weakness, and prolonged paralysis.
    • Contraindications include myasthenia gravis, and hypersensitivity.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Anticholinergics 2 (1) PDF

    Description

    This quiz covers cholinergic antagonists, focusing on their classification into antimuscarinic and antinicotinic drugs. It highlights the properties, mechanisms, and clinical utility of antimuscarinic agents, particularly atropine. Test your understanding of these important pharmacological agents.

    More Like This

    Cholinergic Antagonists and Their Types
    10 questions
    Cholinergic Antagonists
    42 questions

    Cholinergic Antagonists

    PrestigiousAlliteration avatar
    PrestigiousAlliteration
    Use Quizgecko on...
    Browser
    Browser